Abstracts
Objective: To diagnose prostatic cancer (CaP) with cDNA macroarray. Methods: Total RNA was isolated from patients with prostate cancer and from normal people, and poly(A) RNA was further purified. Then differentially expressed genes were analysed in CaP and normal prostate by cDNA macroarray system. Results: There were differential expressions of nine prostate-associated specific genes in CaP as compared with normal prostate, among which, 7 were significantly up-regulated and 2 were down-regulated. Conclusion: As a diagnostic approach at molecular level, the cDNA macroarray is supposed to elevate the detection rate of CaP.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Reference
Marshall A, Hodgson J. DNA chips: an array of possibilities [J]. Nat Biotechnol 1998; 16:27–31.
Calvo A, Xiao N, Kang J, et al. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors [J]. Cancer Res 2002; 62:5325–35.
Brooks JD. Microarray analysis in prostate cancer research [J]. Curr Opin Urol 2002; 12:395–9.
Burger MJ, Tebay MA, Keith PA, et al. Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer [J]. Int J Cancer 2002; 100:228–37.
Ho SM, Lau KM. DNA microarrays in prostate cancer [J]. Curr Urol Rep 2002; 3:53–60.
Luo JH, Yu YP. Genetic factors underlying prostate cancer [J]. Expert Rev Mol Med 2003; 5:1–26.
Gurova KV, Roklin OW, Krivokrysenko VI, et al. Expression of prostate specific antigen (PSA) is negatively regulated by p53 [J]. Oncogene 2002; 21:153–7.
Rubin MA, Dunn R, Strawderman M, et al. Tissue microarray sampling strategy for prostate cancer biomarker analysis [J]. Am J Surg Pathol 2002; 26:312–9.
Porkka KP, Visakorpi T. Molecular mechanisms of prostate cancer [J]. Eur Urol 2004; 45:683–91.
Wong YC, Wang XH, Ling MT. Prostate development and carcinogenesis [J]. Int Rev Cytol 2003; 227:65–130.
Gonzalgo ML, Isaacs WB. Molecular pathways to prostate cancer [J]. J Urol 2003; 170(6 Pt 1):2444–52.
Edwards J, Krishna NS, Witton CJ, Bartlett JM. Gene amplifications associated with the development of hormone-resistant prostate cancer [J]. Clin Cancer Res 2003; 9:5271–81.
Recker F, Kwiatkowski MK, Piironen T, et al. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen [J]. Urology 2000; 55:481–5.
Chaib H, Cockrell EK, Rubin MA, et al. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis [J]. Neoplasia 2001; 3:43–52.
Author information
Authors and Affiliations
Corresponding author
Additional information
Biography: ZHONG Wei-de (1968–), male, associate professor, the First People’s Hospital, Guangzhou Medical College, majors in urology.
Rights and permissions
About this article
Cite this article
Zhong, Wd., Liu, Ls., Liu, Wh. et al. A clinical study on prostate cancer diagnosis with cDNA macroarray. Chin. J. Cancer Res. 17, 66–70 (2005). https://doi.org/10.1007/s11670-005-0014-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-005-0014-5